We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
(+24%)
Cap. Flow
+$552M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$39.4M |
| 3 |
Intel
INTC
|
+$29.2M |
| 4 |
Qualcomm
QCOM
|
+$27.6M |
| 5 |
Danaher
DHR
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$49.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$41.6M |
| 3 |
ARQL
Arqule Inc
ARQL
|
+$26.5M |
| 4 |
Arrowhead Research
ARWR
|
+$24.9M |
| 5 |
Merck
MRK
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.73% |
| 2 | Technology | 19.55% |
| 3 | Financials | 10.18% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Capri Holdings
CPRI
$1.82B
| $8.27M | 0.09% |
216,748
+78,619
| +57% | +$2.71M |
|
252
Cheniere Energy
LNG
$53.6B
| $8.27M | 0.09% |
135,387
+32,898
| +32% | +$2.03M |
|
253
Fidelity National Information Services
FIS
$22.3B
| $8.22M | 0.09% |
59,098
-8,416
| -12% | -$1.13M |
|
|
CERN
254
DELISTED
Cerner Corp
CERN
| $8.21M | 0.09% |
111,920
+10,435
| +10% | +$722K |
|
|
IBKC
255
DELISTED
IBERIABANK Corp
IBKC
| $8.16M | 0.09% |
+109,039
| New | +$8.1M |
|
256
MacroGenics
MGNX
$254M
| $8.14M | 0.09% |
747,763
-7,225
| -1% | -$71.5K |
|
|
QIWI
257
DELISTED
QIWI PLC
QIWI
| $8.13M | 0.09% |
420,000
+54,000
| +15% | +$1.05M |
|
258
Robert Half
RHI
$4.07B
| $8.13M | 0.09% |
128,675
+39,005
| +43% | +$2.26M |
|
259
CEVA Inc
CEVA
$980M
| $8.02M | 0.09% |
297,434
+12,607
| +4% | +$344K |
|
|
GWPH
260
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $7.93M | 0.09% |
75,811
+24,611
| +48% | +$2.76M |
|
261
Parker-Hannifin
PH
$124B
| $7.92M | 0.08% |
38,492
+8,306
| +28% | +$1.61M |
|
262
Corpay
CPAY
$24.8B
| $7.9M | 0.08% |
27,464
+7,772
| +39% | +$2.29M |
|
263
ConocoPhillips
COP
$141B
| $7.79M | 0.08% |
119,835
-658
| -0.5% | -$38.7K |
|
264
VF Corp
VFC
$6.72B
| $7.79M | 0.08% |
78,132
-7,012
| -8% | -$629K |
|
265
Ball Corp
BALL
$17.2B
| $7.68M | 0.08% |
118,767
+74,290
| +167% | +$5.03M |
|
266
Edwards Lifesciences
EW
$47.8B
| $7.61M | 0.08% |
97,842
+5,835
| +6% | +$456K |
|
267
US Bancorp
USB
$98.9B
| $7.58M | 0.08% |
127,834
-1,830
| -1% | -$106K |
|
268
Truist Financial
TFC
$63.7B
| $7.55M | 0.08% |
+134,088
| New | +$7.26M |
|
269
Boeing
BA
$167B
| $7.42M | 0.08% |
22,774
+6,980
| +44% | +$2.47M |
|
270
Campbell Soup
CPB
$6.67B
| $7.4M | 0.08% |
149,738
+44,950
| +43% | +$2.13M |
|
271
Reinsurance Group of America
RGA
$15.7B
| $7.36M | 0.08% |
45,163
+4,195
| +10% | +$679K |
|
272
Equitable Holdings
EQH
$13.3B
| $7.36M | 0.08% |
297,026
+176,554
| +147% | +$4.09M |
|
273
The Mosaic Company
MOS
$7.1B
| $7.21M | 0.08% |
332,976
+141,890
| +74% | +$2.81M |
|
274
Theravance Biopharma
TBPH
$874M
| $7.19M | 0.08% |
277,700
-2,000
| -0.7% | -$38.9K |
|
|
IPG
275
DELISTED
Interpublic Group of Companies
IPG
| $7.18M | 0.08% |
310,756
+62,596
| +25% | +$1.38M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2019 Portfolio in Review
As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.
- Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
- Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
- Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
- Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
- Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
- Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
- Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.
Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.